Publicaciones (116) Publicaciones en las que ha participado algún/a investigador/a

2020

  1. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis

    Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 1, pp. 87-101

  2. A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2

    Scientific Reports, Vol. 10, Núm. 1

  3. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

  4. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells

    Nature, Vol. 583, Núm. 7816, pp. 447-452

  5. A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL

    Digestive and Liver Disease, Vol. 52, Núm. 8, pp. 857-861

  6. A new generation of vaccines based on alphavirus self-amplifying RNA

    Current Opinion in Virology, Vol. 44, pp. 145-153

  7. A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma

    Cancers, Vol. 12, Núm. 6

  8. A proposed approach to chronic airway disease (CAD) using therapeutic goals and treatable traits: A look to the future

    International Journal of COPD, Vol. 15, pp. 2091-2100

  9. Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome

    Frontiers in Cell and Developmental Biology, Vol. 8

  10. Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells

    Journal of the American Society of Nephrology, Vol. 31, Núm. 9, pp. 1996-2012

  11. Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion

    Journal of Cell Biology, Vol. 219, Núm. 9

  12. Antioxidant lifestyle, Co-morbidities and quality of life empowerment concerning liver fibrosis

    Antioxidants, Vol. 9, Núm. 11, pp. 1-13

  13. Asociación entre hígado graso no alcohólico, riesgo metabólico y vascular

    Clínica e investigación en arteriosclerosis, Vol. 32, Núm. 5, pp. 200-205

  14. Association between non alcoholic fatty liver disease, metabolic and vascular risk

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 5, pp. 200-205

  15. Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma

    Journal of Hepatology, Vol. 73, Núm. 6, pp. 1460-1469

  16. Association of the SH2B1 RS7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease

    Nutrients, Vol. 12, Núm. 5

  17. Biomarcadores metabolómicos predictores de la caída del FEV1 en fumadores sanos y pacientes con EPOC ligera-moderada

    Revista española de patología torácica, Vol. 32, Núm. 1, pp. 37-37

  18. Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

    Journal for immunotherapy of cancer, Vol. 8, Núm. 1

  19. Brain ventricular enlargement in human and murine acute intermittent porphyria

    Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223

  20. Cardiovascular risk, Metabolic disease and NASH control for Health Empowerment: Future endeavours

    Clínica e investigación en arteriosclerosis, Vol. 32, Núm. 5, pp. 206-208